142 related articles for article (PubMed ID: 35456449)
1. Optical Genome Mapping and Single Nucleotide Polymorphism Microarray: An Integrated Approach for Investigating Products of Conception.
Sahajpal NS; Mondal AK; Ananth S; Pundkar C; Jones K; Williams C; Fee T; Weissman A; Tripodi G; Oza E; Gavrilova-Jordan L; Omar N; Hastie AR; DuPont BR; Layman L; Chaubey A; Kolhe R
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456449
[TBL] [Abstract][Full Text] [Related]
2. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
3. Detection of cytogenomic abnormalities by OncoScan microarray assay for products of conception from formalin-fixed paraffin-embedded and fresh fetal tissues.
Wen J; Grommisch B; DiAdamo A; Chai H; Ng SME; Hui P; Bale A; Mak W; Wang G; Li P
Mol Cytogenet; 2021 Apr; 14(1):21. PubMed ID: 33810806
[TBL] [Abstract][Full Text] [Related]
4. Reflex fluorescent in situ hybridization testing for unsuccessful product of conception cultures: a retrospective analysis of 5555 samples attempted by conventional cytogenetics and fluorescent in situ hybridization.
Shearer BM; Thorland EC; Carlson AW; Jalal SM; Ketterling RP
Genet Med; 2011 Jun; 13(6):545-52. PubMed ID: 21415758
[TBL] [Abstract][Full Text] [Related]
5. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
6. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
[TBL] [Abstract][Full Text] [Related]
7. Single-Nucleotide Polymorphism-Microarray Ploidy Analysis of Paraffin-Embedded Products of Conception in Recurrent Pregnancy Loss Evaluations.
Maslow BS; Budinetz T; Sueldo C; Anspach E; Engmann L; Benadiva C; Nulsen JC
Obstet Gynecol; 2015 Jul; 126(1):175-81. PubMed ID: 26241271
[TBL] [Abstract][Full Text] [Related]
8. Development of a Chromosomal Microarray Test for the Detection of Abnormalities in Formalin-Fixed, Paraffin-Embedded Products of Conception Specimens.
Gliem TJ; Aypar U
J Mol Diagn; 2017 Nov; 19(6):843-847. PubMed ID: 28807814
[TBL] [Abstract][Full Text] [Related]
9. Genomic imbalance in products of conception: single-nucleotide polymorphism chromosomal microarray analysis.
Levy B; Sigurjonsson S; Pettersen B; Maisenbacher MK; Hall MP; Demko Z; Lathi RB; Tao R; Aggarwal V; Rabinowitz M
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):202-209. PubMed ID: 25004334
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
Díaz-González Á; Mora E; Avetisyan G; Furió S; De la Puerta R; Gil JV; Liquori A; Villamón E; García-Hernández C; Santiago M; García-Ruiz C; Llop M; Ferrer-Lores B; Barragán E; García-Palomares S; Mayordomo E; Luna I; Vicente A; Cordón L; Senent L; Álvarez-Larrán A; Cervera J; De la Rubia J; Hernández-Boluda JC; Such E
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297002
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic studies of spontaneous miscarriages: a seven year study to compare significance of primary vs. secondary culture methods for assessment of fetal karyotype yield and maternal cell contamination.
Yusuf RZ; Naeem R
Early Pregnancy (Cherry Hill); 2001 Apr; 5(2):121-31. PubMed ID: 11753525
[TBL] [Abstract][Full Text] [Related]
12. Reducing misdiagnosis caused by maternal cell contamination in genetic testing for early pregnancy loss.
Volozonoka L; Gailite L; Perminov D; Kornejeva L; Fodina V; Kempa I; Miskova A
Syst Biol Reprod Med; 2020 Dec; 66(6):410-420. PubMed ID: 33059488
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues.
Lyons-Weiler M; Hagenkord J; Sciulli C; Dhir R; Monzon FA
Diagn Mol Pathol; 2008 Mar; 17(1):3-13. PubMed ID: 18303412
[TBL] [Abstract][Full Text] [Related]
14. Salvage of fetal karyotype information from SNP array data obtained from products of conception with maternal cell contamination.
Sasaki K; Abe K; Mori T; Hashimoto K; Nakabayashi K
Prenat Diagn; 2017 Aug; 37(8):781-787. PubMed ID: 28591488
[TBL] [Abstract][Full Text] [Related]
15. Informatics enhanced SNP microarray analysis of 30 miscarriage samples compared to routine cytogenetics.
Lathi RB; Massie JA; Loring M; Demko ZP; Johnson D; Sigurjonsson S; Gemelos G; Rabinowitz M
PLoS One; 2012; 7(3):e31282. PubMed ID: 22403611
[TBL] [Abstract][Full Text] [Related]
16. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of microarray testing in pregnancy loss.
Rosenfeld JA; Tucker ME; Escobar LF; Neill NJ; Torchia BS; McDaniel LD; Schultz RA; Chong K; Chitayat D
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):478-86. PubMed ID: 25846569
[TBL] [Abstract][Full Text] [Related]
18. Optical Genome Mapping for Oncology Applications.
Sahajpal NS; Mondal AK; Hastie A; Chaubey A; Kolhe R
Curr Protoc; 2023 Oct; 3(10):e910. PubMed ID: 37888957
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics.
Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X
Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386
[TBL] [Abstract][Full Text] [Related]
20. Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays.
Mirza MK; Sukhanova M; Stölzel F; Onel K; Larson RA; Stock W; Ehninger G; Kuithan F; Zöphel K; Reddy P; Joseph L; Raca G
Leuk Res; 2014 Sep; 38(9):1091-6. PubMed ID: 25088808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
